Methylation profiles at birth linked to early childhood obesity

Delphine Lariviere,Sarah J.C. Craig,Ian M. Paul,Emily E. Hohman,Jennifer S. Savage,Robert O. Wright,Francesca Chiaromonte,Kateryna D. Makova,Matthew L. Reimherr
DOI: https://doi.org/10.1101/2024.01.12.24301172
2024-01-13
Abstract:Childhood obesity represents a significant global health concern and identifying risk factors is crucial for developing intervention programs. Many ‘omics’ factors associated with the risk of developing obesity have been identified, including genomic, microbiomic, and epigenomic factors. Here, using a sample of 48 infants, we investigated how the methylation profiles in cord blood and placenta at birth were associated with weight outcomes (specifically, conditional weight gain, body mass index, and weight-for-length ratio) at age six months. We characterized genome-wide DNA methylation profiles using the Illumina Infinium MethylationEpic chip, and incorporated information on child and maternal health, and various environmental factors into the analysis. We used regression analysis to identify genes with methylation profiles most predictive of infant weight outcomes, finding a total of 23 relevant genes in cord blood and 10 in placenta. Notably, in cord blood, the methylation profiles of three genes ( and ) were associated with all three weight outcomes, which are also associated with weight outcomes in an independent cohort suggesting a strong relationship with weight trajectories in the first six months after birth. Additionally, we developed a Methylation Risk Score (MRS) that could be used to identify children most at risk for developing childhood obesity. While many of the genes identified by our analysis have been associated with weight-related traits (e.g., glucose metabolism, BMI, or hip-to-waist ratio) in previous genome-wide association and variant studies, our analysis implicated several others, whose involvement in the obesity phenotype should be evaluated in future functional investigations.
Genetic and Genomic Medicine
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore whether the methylation profiles in umbilical cord blood and placenta at birth are associated with the weight gain of infants in the first six months after birth. Specifically, the researchers hope to find out how these methylation profiles affect the infants' Conditional Weight Gain (CWG), Body Mass Index (BMI) and Weight - for - Length Ratio by analyzing samples from 48 infants. The goal of the study is to identify genes whose methylation levels are significantly associated with early infant weight gain, thereby providing new biological markers and intervention targets for preventing childhood obesity. The study characterized the whole - genome DNA methylation profiles using the Illumina Infinium MethylationEpic chip and conducted a comprehensive analysis in combination with the health information of children and mothers and various environmental factors. Through regression analysis, the researchers identified 23 genes most related to infant weight outcomes in umbilical cord blood and 10 genes related to infant weight outcomes in the placenta. Notably, in umbilical cord blood, the methylation profiles of three genes (PLIN4, UBE2F and PPP1R16B) are associated with all three weight outcomes, indicating that these genes may play an important role in the weight gain trajectory of infants after birth. In addition, the study also developed a Methylation Risk Score (MRS), which can be used to identify individuals who are most likely to develop childhood obesity. Although many of the genes identified through the analysis have been previously associated with weight - related traits (such as glucose metabolism, BMI or waist - to - hip ratio) in studies, this study also pointed out several new genes, and their roles in the obesity phenotype need to be further evaluated in future functional studies.